Stockscreener 앱 받기
31.80
2.15%
-0.70
전일 마감가:
$32.50
열려 있는:
$32.81
하루 거래량:
24,014
Relative Volume:
0.45
시가총액:
$125.25M
수익:
$17,000
순이익/손실:
$-31.08M
주가수익비율:
-9.503
EPS:
-3.3463
순현금흐름:
$-24.86M
1주 성능:
-0.53%
1개월 성능:
-22.76%
6개월 성능:
+31.19%
1년 성능:
+46.41%
1일 변동 폭
$31.73
$33.02
1주일 범위
$29.18
$33.32
52주 변동 폭
$14.00
$44.00
Vtv Therapeutics Inc Stock (VTVT) Company Profile
명칭
Vtv Therapeutics Inc
전화
336-841-0300
주소
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
31.80 | 125.25M | 17,000 | -31.08M | -24.86M | -3.3463 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-12 | 개시 | Evercore ISI | Outperform |
| 2026-01-23 | 개시 | Roth Capital | Buy |
| 2026-01-05 | 개시 | TD Cowen | Buy |
| 2025-11-19 | 개시 | BTIG Research | Buy |
| 2019-05-30 | 개시 | H.C. Wainwright | Buy |
| 2018-04-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-08 | 개시 | ROTH Capital | Buy |
| 2018-02-08 | 개시 | Northland Capital | Outperform |
| 2016-09-26 | 개시 | H.C. Wainwright | Buy |
| 2015-09-04 | 개시 | Canaccord Genuity | Buy |
| 2015-08-24 | 개시 | Piper Jaffray | Overweight |
| 2015-08-24 | 개시 | Stifel | Buy |
모두보기
Vtv Therapeutics Inc 주식(VTVT)의 최신 뉴스
MSN Money - MSN
Wall Street analysts think vTv Therapeutics (VTVT) could surge 31.58%: Read this before placing a bet - MSN
vTv Therapeutics (VTVT) Stock: Is It Worth Opening a Position | Q4 2025: Earnings Beat EstimatesSlow Growth - Newser
vTv Therapeutics (NASDAQ: VTVT) details 2026 virtual annual meeting, board and pay - Stock Titan
vTv Therapeutics Inc. (NASDAQ:VTVT) Short Interest Update - MarketBeat
(VTVT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
VTVT (vTv Therapeutics) posts far narrower Q4 2025 loss than expected, yet shares drop six percent today. - Newser
Roth Capital initiates coverage of VTV Therapeutics (VTVT) with buy recommendation - MSN
vTv Therapeutics (NASDAQ:VTVT) Stock Passes Below Fifty Day Moving AverageTime to Sell? - MarketBeat
vTv Therapeutics Inc. delivers 47.7% EPS beat exceeding analyst forecastsPro Trader Recommendations - Cổng thông tin điện tử tỉnh Lào Cai
VTVT vTv Therapeutics posts far narrower Q4 2025 loss than analyst estimates, shares rise modestly.Margin Improvement - Cổng thông tin điện tử tỉnh Tây Ninh
VTVT (vTv Therapeutics Inc.) narrower than expected Q4 2025 loss pushes shares 3.73% higher on upbeat investor sentiment.Crowd Risk Alerts - Xã Châu Thành
Millennium Management LLC Increases Stake in vTv Therapeutics Inc - GuruFocus
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High? - Yahoo Finance
VTVT Forecast, Price Target & Analyst Ratings | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
Millennium entities, Israel A. Englander disclose stakes in vTv Therapeutics (VTVT) - Stock Titan
Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Grows By 24.6% - MarketBeat
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Liquidity Mapping Around (VTVT) Price Events - Stock Traders Daily
BTIG reiterates Buy on vTv Therapeutics stock, keeps $49 target By Investing.com - Investing.com Canada
Sentiment Recap: Will vTv Therapeutics Inc outperform the market in YEAR2026 Sector Moves & Weekly Chart Analysis and Guides - baoquankhu1.vn
Investment Review: Will vTv Therapeutics Inc benefit from green energy policiesPortfolio Performance Summary & AI Forecasted Stock Moves - baoquankhu1.vn
BTIG reiterates Buy on vTv Therapeutics stock, keeps $49 target - Investing.com
Published on: 2026-04-11 18:49:35 - baoquankhu1.vn
Market Leaders: Whats next for vTv Therapeutics Inc stock2026 Analyst Calls & Consistent Profit Alerts - baoquankhu1.vn
VTVT Technical Analysis | Trend, Signals & Chart Patterns | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
Aug Shorts: Will vTv Therapeutics Inc face regulatory challengesDividend Hike & Weekly Market Pulse Updates - baoquankhu1.vn
VTV Therapeutics (VTVT) reports $27M 2025 net loss amid cadisegliatin advancements - MSN
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Sahm
New vTv hire gets 4,000 stock options priced at $39.54 - Stock Titan
Growth Recap: Will vTv Therapeutics Inc outperform the market in YEAR2026 Short Interest & Smart Money Movement Tracker - baoquankhu1.vn
We're Not Worried About VTv Therapeutics' (NASDAQ:VTVT) Cash Burn - Moomoo
Why (VTVT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet - sharewise.com
VTVT SEC FilingsVtv Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Millennium Management LLC Acquires Shares in vTv Therapeutics Inc - GuruFocus
VTVT Stock Analysis: vTv Therapeutics Inc. Biotech Rises 2.19 Percent to 40.53 - Cổng thông tin điện tử tỉnh Lào Cai
VTVT Technical Analysis & Stock Price Forecast - Intellectia AI
Aug PostEarnings: How does vTv Therapeutics Inc score in quality rankingsStop Loss & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
vTv Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Analysts’ Opinions Are Mixed on These Healthcare Stocks: vTv Therapeutics (VTVT) and CSPC Pharmaceutical Group (OtherCHJTF) - The Globe and Mail
Millennium Management (NASDAQ: VTVT) reports a 5.0% holding in vTv - Stock Titan
Technical Analysis: Will vTv Therapeutics Inc outperform the market in YEAR2026 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
Vtv Therapeutics Inc (VTVT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):